COMMUNIQUÉS West-GlobeNewswire

Eurobio Scientific: RESULTS FOR THE 1ST HALF OF 2024

24/09/2024 - 18:00

RESULTS FOR THE 1 ST HALF OF 2024 Revenues up 12% on a like-for-like basis (24% overall) Stable adjusted EBITDA 1 and operating profit Net financial debt down slightly to €1.6m, with cash of €86.6m Proposed voluntary [...]

Bavarian Nordic Awarded USD 63 Million from the U.S. Government for Production and Supply of Additional Smallpox/Mpox Vaccines

24/09/2024 - 17:30

Contract will further strengthen the U.S, bulk vaccine inventory and secure additional freeze-dried doses Deliveries planned for 2025 and beyond COPENHAGEN, Denmark, September 24, 2024 – Bavarian Nordic A/S (OMX: BAVA) [...]

Tevogen Bio Leadership Meets Members of U.S. Congress to Advocate for Long COVID Patients and Highlights Achievements and Assets as a Blueprint for Biotech Innovation

24/09/2024 - 17:09

WARREN, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified [...]

Appointment of Dr. Kalpesh Barot, MD Completes Phase One of ADIA Nutrition’s Medical Division

24/09/2024 - 16:00

WINTER PARK, Fla., Sept. 24, 2024 (GLOBE NEWSWIRE) -- ADIA Nutrition (OTC Pink: ADIA) is excited to announce the completion of its Board of Medical Directors with the appointment of Dr. Kalpesh Barot, MD, a [...]

NeuroOne® Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference

24/09/2024 - 15:30

Minimally invasive technology would allow for percutaneous placement of a paddle electrode Renowned pain specialist Dr. Sean Li to present on this innovative tool for lower back pain EDEN PRAIRIE, Minn., Sept. 24, 2024 [...]

AAMI, CTA to Collaborate on AI Standards

24/09/2024 - 15:25

Arlington, Virginia, Sept. 24, 2024 (GLOBE NEWSWIRE) -- As artificial intelligence (AI) becomes more integrated into the healthcare sector, there is a pressing need for industry standards that will protect patients and [...]

GT Biopharma to Host Virtual KOL Event Showcasing its NK Cell Engager Pipeline and Broad Indication Potential on October 10, 2024

24/09/2024 - 15:15

SAN FRANCISCO, CALIFORNIA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the [...]

Lighthouse Autism Center Announces Expansion of ABA Services in Iowa

24/09/2024 - 15:00

Leading ABA Provider Set to Open Newest Location in Cedar Rapids, IA. CEDAR RAPIDS, Iowa, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Lighthouse Autism Center, a premier provider of center-based Applied Behavior Analysis (ABA) [...]

Georgiamune Announces First Participant Dosed in First-In-Class Phase 1 Healthy Volunteers Trial of GIM-407

24/09/2024 - 15:00

Georgiamune continues biotech innovation streak with first autoimmune disease-focused program based on novel biology GAITHERSBURG, Md., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Today, Georgiamune Inc . , a privately held, [...]

Conception Nurseries Launches TrueClones™ X

24/09/2024 - 15:00

The Industry’s First Generation Zero Hardened Tissue-Cultured Clones Provides Cannabis Cultivators With a Faster Path to Profit SACRAMENTO, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) -- Conception Nurseries , the world’s [...]

Tersa Earth and Silica-X Sign MoU to Revolutionize Mining and Waste Management with AI-Powered Biotech and Zero-Waste Solutions

24/09/2024 - 15:00

NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Fresh off its recognition as a Top Innovator in the World Economic Forum’s (WEF) Sustainable Mining Challenge, Tersa Earth Innovations Inc. announces signing a Memorandum of [...]

Curium Announces the Official Opening its New Netherlands Facility for the Production of Lutetium-177 – a Game Changer Therapy Isotope for Cancer Patients Worldwide

24/09/2024 - 14:45

The new Lu-177 production facility further solidifies Curium’s position as a global leader in nuclear medicine Curium will ensure a continuous supply of Lu-177 to benefit more than 100,000 cancer patients worldwide over [...]

Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology – Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference

24/09/2024 - 14:45

VANCOUVER, British Columbia, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) reports that it will be presenting the Company’s [...]

Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration

24/09/2024 - 14:30

Boehringer is advancing the development of SZN-413 to prepare it for potential future clinical testing SZN-413 is a bi-specific antibody targeting Frizzled Class Receptor 4 (Fzd4) mediated Wingless/Integrated (Wnt) [...]

CytoDyn Announces Preliminary Findings in Study with SMC Laboratories

24/09/2024 - 14:30

VANCOUVER, Washington, Sept. 24, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple [...]

Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials

24/09/2024 - 14:30

An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database for Oral Simufilam in On-going Phase 3 Trials. The DSMB Recommended Both Phase 3 Trials Continue as Planned, [...]

Enlivex Announces Positive DSMB Recommendation to Initiate the Phase II Stage of its Phase I/II Trial of Allocetra in Patients with Moderate to Severe Knee Osteoarthritis

24/09/2024 - 14:30

Nes-Ziona, Israel, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the independent Data [...]

Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results

24/09/2024 - 14:01

Hamilton, Bermuda, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Company to host conference call today at 8.30 a.m. ET Continued progress within core activities in RNA delivery, supported by move into new R&D facilities [...]

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX”

24/09/2024 - 14:01

TRxADE Health, Inc. today announced that it changed its name and ticker symbol to “Scienture Holdings, Inc.” and “SCNX”, respectively, and that the business will continue as a Nasdaq-listed company. TAMPA, FL, Sept. 24 [...]